| Report ID | 279214 |
| Drug Identification Number | 01934791 |
| Brand name | ROBAXISAL C 1/2 |
| Common or Proper name | methocarbamol, codeine phosphate and acetylsalicylic acid tablets |
| Company Name | GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | ACETYLSALICYLIC ACID CODEINE PHOSPHATE METHOCARBAMOL |
| Strength(s) | 325MG 32.4MG 400MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 250ct, 24ct |
| ATC code | N02AA |
| ATC description | OPIOIDS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2025-12-15 |
| Remaining supply date | |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | Last lots expire 30/09/2026 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 55 STANDISH COURT MISSISSAUGA, ONTARIO CANADA L5R 4B2 |
| Company contact information |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2026-03-02 | French | Compare |
| v1 | 2026-03-02 | English | Compare |
Showing 1 to 2 of 2